Form 4: Eli Lilly Director Acquires LLY Stock Units

Eli Lilly & Co. Director Mary Lynne Hedley acquired 9.336 shares of common stock, valued at $1,062.19 per share, as deferred compensation.

Summary

• Mary Lynne Hedley, a Director at Eli Lilly & Co. (LLY), acquired 9.336 shares of common stock.
• The transaction occurred on December 15, 2025, with shares priced at $1,062.19 each.
• These shares were acquired as deferred compensation under the Lilly Directors' Deferral Plan, in lieu of cash.
• The acquired shares will be settled in common stock following Ms. Hedley's separation from service.
• Following this transaction, Ms. Hedley directly beneficially owns 2,252.694 shares and indirectly owns 98 shares through a trust.

Sentiment

Score: 6

Explanation: Slightly positive. A director acquiring shares, even as deferred compensation, generally signals confidence in the company's future. It's a routine compensation event, not a major market-moving transaction, hence not a high score.

Positives

• A Director acquiring shares, even as deferred compensation, can signal confidence in the company's future performance.
• The deferral plan aligns the director's long-term interests with those of shareholders.

Future Outlook

The acquired shares, deferred as stock units, will be settled in common stock following the reporting person's separation from service, indicating a future payout event tied to continued service.

Industry Context

This transaction is a routine insider filing, common in publicly traded companies where directors receive compensation in the form of equity or deferred equity units to align their interests with shareholders. It reflects standard corporate governance practices for director compensation within the pharmaceutical industry.

Comparison to Industry Standards

• The practice of compensating directors with equity or deferred equity units is a common industry standard across large-cap pharmaceutical companies like Pfizer, Johnson & Johnson, and Merck, aiming to align director incentives with long-term shareholder value.
• The use of a Directors' Deferral Plan is a standard mechanism to allow directors to defer compensation, often for tax planning purposes, while maintaining an equity interest in the company.

Corporate Governance

Related Party Transactions

• The acquisition of shares by a director as compensation is a related party transaction, specifically director remuneration.

Stakeholder Impact

• Shareholders: Minor positive impact, as director equity ownership aligns interests.

Next Steps

• Settlement of the acquired stock units in common stock following Mary Lynne Hedley's separation from service.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction related to director compensation. While a director acquiring shares can be seen as a positive signal of confidence, the small number of shares and the nature of it being deferred compensation mean it is not a significant market-moving event. It does not provide enough new information to warrant a change in investment recommendation, thus a 'hold' stance is appropriate, maintaining existing positions based on broader company fundamentals.

Keywords

Eli Lilly, LLY, Insider Transaction, Form 4, Director Compensation, Stock Acquisition, Deferred Compensation, Mary Lynne Hedley